EA201001836A1 - Метод экспрессного обнаружения наркотиков в конфискованных пробах веществ - Google Patents

Метод экспрессного обнаружения наркотиков в конфискованных пробах веществ

Info

Publication number
EA201001836A1
EA201001836A1 EA201001836A EA201001836A EA201001836A1 EA 201001836 A1 EA201001836 A1 EA 201001836A1 EA 201001836 A EA201001836 A EA 201001836A EA 201001836 A EA201001836 A EA 201001836A EA 201001836 A1 EA201001836 A1 EA 201001836A1
Authority
EA
Eurasian Patent Office
Prior art keywords
sample
samples
sfo
morphine
control
Prior art date
Application number
EA201001836A
Other languages
English (en)
Other versions
EA018395B1 (ru
Inventor
Сергей Бабиченко
Татьяна Ивкина
Лариса Порывкина
Виталий Соминский
Original Assignee
Нартест Интернэшинал Ас
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Нартест Интернэшинал Ас filed Critical Нартест Интернэшинал Ас
Publication of EA201001836A1 publication Critical patent/EA201001836A1/ru
Publication of EA018395B1 publication Critical patent/EA018395B1/ru

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9486—Analgesics, e.g. opiates, aspirine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/27—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands using photo-electric detection ; circuits for computing concentration
    • G01N21/274—Calibration, base line adjustment, drift correction
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N2021/6417—Spectrofluorimetric devices
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N2021/6417—Spectrofluorimetric devices
    • G01N2021/6421—Measuring at two or more wavelengths
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/141111—Diverse hetero atoms in same or different rings [e.g., alkaloids, opiates, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mathematical Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Изобретение касается обнаружения героина и морфия в незаконных образцах наркотиков, а также для их разделения. Приготавливают жидкую пробу, полученную из изъятого образца, и разделяют ее на две равные аликвотные пробы, причем одна проба является контрольной, а другая главной. Оба образца обрабатывают соляной кислотой и гидроокисью натрия, которые вводят в образцы с разной последовательностью. После чего проводят измерение СФО контрольной пробы. Далее обнаруживают присутствие специфического спектрального образца морфия в измеренном СФО контрольной пробы и фиксируют величину интенсивности СФО в особой спектральной точке (контрольная величина). После 15 мин подкисления главного образца проводят аналогичные измерения и обнаружение морфия в главном образце.
EA201001836A 2008-07-07 2008-07-07 Метод экспрессного обнаружения наркотиков в конфискованных пробах веществ EA018395B1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2008/058738 WO2010003447A1 (en) 2008-07-07 2008-07-07 Method for on-site drug detection in illicit drug samples

Publications (2)

Publication Number Publication Date
EA201001836A1 true EA201001836A1 (ru) 2011-06-30
EA018395B1 EA018395B1 (ru) 2013-07-30

Family

ID=40210846

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201001836A EA018395B1 (ru) 2008-07-07 2008-07-07 Метод экспрессного обнаружения наркотиков в конфискованных пробах веществ

Country Status (5)

Country Link
US (1) US8404488B2 (ru)
EP (1) EP2300831B1 (ru)
EA (1) EA018395B1 (ru)
ES (1) ES2449746T3 (ru)
WO (1) WO2010003447A1 (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10330603B1 (en) * 2016-04-08 2019-06-25 Michael D. Callahan Mass produced, low cost, portable test kit for the detection and identification of chemical and biological agents
US9759733B1 (en) 2016-04-08 2017-09-12 Michael D. Callahan Mass produced, low cost, portable test kit for the detection and identification of narcotics
TWI663400B (zh) 2017-09-28 2019-06-21 國立臺灣大學 檢測試紙及檢測毒品的方法
JP6985730B2 (ja) * 2017-11-17 2021-12-22 株式会社日立ハイテクサイエンス 試料分析システム、表示方法及び試料分析方法
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005111586A1 (en) * 2004-05-13 2005-11-24 As Laser Diagnostic Instruments A portable device and method for on-site detection and quantification of drugs
DE602006013361D1 (de) * 2006-10-03 2010-05-12 Nartest Internat As Verfahren zum on-site-drogennachweis bei illegalen drogenproben

Also Published As

Publication number Publication date
US8404488B2 (en) 2013-03-26
EA018395B1 (ru) 2013-07-30
US20110151570A1 (en) 2011-06-23
EP2300831B1 (en) 2013-12-04
WO2010003447A1 (en) 2010-01-14
EP2300831A1 (en) 2011-03-30
ES2449746T3 (es) 2014-03-21

Similar Documents

Publication Publication Date Title
WO2009090553A3 (en) Compositions and methods of detecting post-stop peptides
MX2016006455A (es) Dispositivo integrado de fuente-pixel activo para el analisis rapido de especimenes biologicos y quimicos.
EP3757225A3 (en) Pancreatic cancer detection kit or device, and detection method
EA201001836A1 (ru) Метод экспрессного обнаружения наркотиков в конфискованных пробах веществ
MX343327B (es) Ensayos para detectar autoanticuerpos contra farmacos anti-tnfa.
WO2012162165A3 (en) Antibodies to 25-hydroxyvitamin d2 and d3 and uses thereof
ZA200701188B (en) Use of C3a and derivatives thereof as a biomarker for colorectal ademona and/or carcinoma; diagnosis method and test system using the same
MX2012004877A (es) Analisis para la deteccion de farmacos anti-tnf y autoanticuerpos.
SG194233A1 (en) Identification of polynucleotides associated with a sample
DK1991697T3 (da) DNA-konformation (LOOP-strukturer) ved normal og anormal genekspression
WO2005073713A3 (en) A method for standardization of chemical and therapeutic values of foods & medicines using animated chromatographic fingerprinting
HK1115636A1 (en) Use of cyfra 21-1 as a marker for colorectal cancer cyfra 21-1
WO2011015602A3 (en) Lung cancer biomarkers
MX2018001697A (es) Método para la cuantificación de los miembros del filogrupo i y/o del filogrupo ii de faecalibacterium prausnitzii y el uso de los mismos como biomarcadores.
WO2010136163A8 (en) Secernin-1 as a marker for cancer
MX2021009528A (es) Prueba de diagnostico basada en fragmento de rgma.
WO2015077382A3 (en) Combined cytology and molecular testing for early detection of esophageal adenocarcinoma
IN2015DN01608A (ru)
WO2014140570A3 (en) Eluate analysis and collection
WO2006066917A3 (en) Use of asc as a marker for colorectal cancer
MX341181B (es) Metodo para someter a prueba a un sujeto que se cree esta predispuesto a tener cancer metastasico usando delta133p53beta.
WO2010000467A8 (en) Asc as a marker for lung cancer
EP2589666A4 (en) ACF DETECTION METHOD
EP3878979A3 (en) Molecular detection of enterovirus and parechovirus
GB2569932A (en) Identification and use of very long chain dicarboxylic acids for disease diagnosis, chemoprevention, and treatment

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): KZ

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): BY RU